| Patents for A61P 11 - Drugs for disorders of the respiratory system (87,767) |
|---|
| 08/13/2009 | WO2009098901A1 3,8-diaminotetrahydroquinoline derivative |
| 08/13/2009 | WO2009098455A1 2- (9h-xanthen-9-yl) -oxazol derivatives as m3 muscarinic receptor antagonists for the treatment of asthma and chronic obstructive lung disease |
| 08/13/2009 | WO2009098453A1 Azonia bicycloalkanes as m3 muscarinic acetylcholin receptor antagonists |
| 08/13/2009 | WO2009098448A1 Compounds |
| 08/13/2009 | WO2009098320A2 Macrolides for treating diseases mediated through pde inhibition |
| 08/13/2009 | WO2009098061A1 Spirocyclic heterocycles, medicaments containing said compounds, use thereof and method for their production |
| 08/13/2009 | WO2009074575A3 Organic compounds |
| 08/13/2009 | WO2009043477A3 Use of glpl (7-36) alone or in combination with leptin 22-56 as a therapeutic agent |
| 08/13/2009 | WO2009043436A3 Use of af12198 as a therapeutic agent |
| 08/13/2009 | WO2009040031A3 Use of a peptide as a therapeutic agent |
| 08/13/2009 | WO2009039991A3 Use of aviptadil as a therapeutic agent |
| 08/13/2009 | WO2009039964A3 Use of glucagon-like peptide as a therapeutic agent |
| 08/13/2009 | WO2009033792A3 Gamma 1 msh alone or in combination with pentagastrin as a therapeutic agent |
| 08/13/2009 | WO2009033770A3 Calcitonin c-terminal flanking peptide for use as a therapeutic agent |
| 08/13/2009 | US20090203767 Inhibition stat-1 |
| 08/13/2009 | US20090203760 CYCLIC AGONISTS AND ANTAGONISTS OF C5a RECEPTORS AND G PROTEIN-COUPLED RECEPTORS |
| 08/13/2009 | US20090203753 7-(2-amino-1-hydroxy-ethyl)-4-hydroxybenzothiazol-2(3H)-one-derivatives as beta2 adrenoreceptor agonists |
| 08/13/2009 | US20090203752 Compounds for nonsense suppression, and methods for their use |
| 08/13/2009 | US20090203739 Anti-Inflammatory Agents |
| 08/13/2009 | US20090203733 Pharmaceutical composition |
| 08/13/2009 | US20090203732 Thiazolones for Use as P13 Kinase Inhibitors |
| 08/13/2009 | US20090203719 Enhancing treatment of mdr cancer with adenosine a3 antagonists |
| 08/13/2009 | US20090203677 Dual Pharmacophores - PDE4-Muscarinic Antagonistics |
| 08/13/2009 | US20090203672 Substituted Sulfonamide Compounds |
| 08/13/2009 | US20090203657 Dual Pharmacophores - PDE4-Muscarinic Antagonistics |
| 08/13/2009 | US20090202633 Extended release formulations of guaifenesin |
| 08/13/2009 | US20090202575 Immunostimulatory nucleic acid molecules |
| 08/13/2009 | US20090202568 Binding members for interleukin-4 receptor alpha (IL-4Ra)-173 |
| 08/13/2009 | US20090202506 loading antigen presenting cells from a subject; loading antigen presenting cells (APC's) having Class I MHC (major histocompatibility factor) molecules with T cell epitopes; culturing CD8+ T cells with APC's; expanding in culture; for allergic asthma |
| 08/13/2009 | DE202008008532U1 Lutschzusammensetzung zur Behandlung von entzündlichen Erkrankungen des Mund- und Rachenraums Sucking composition for the treatment of inflammatory diseases of the mouth and throat |
| 08/13/2009 | DE102008007440A1 Aminosäurederivate als Arzneistoffe Amino acid derivatives as drugs |
| 08/13/2009 | DE102008007381A1 Amidine und Guanidine und deren Derivate zur Behandlung von Krankheiten Amidines and guanidines and their derivatives for the treatment of diseases |
| 08/13/2009 | DE102008007198A1 Oral oder nasal applizierbare Epinephrin- haltige Zubereitungen mit verbesserten Eigenschaften Orally or nasally administered epinephrine-containing formulations with improved properties |
| 08/13/2009 | CA2714480A1 3,8-diaminotetrahydroquinoline derivative |
| 08/13/2009 | CA2714426A1 Methods and compositions for treating respiratory disease |
| 08/13/2009 | CA2714419A1 Dual pharmacophores - pde4-muscarinic antagonistics |
| 08/13/2009 | CA2714418A1 Dual pharmacophores - pde4 -muscarinic antagonistics |
| 08/13/2009 | CA2714389A1 Macrolides and uses of macrolides |
| 08/13/2009 | CA2714352A1 Dual pharmacophores-pde4-muscarinic antagonistics |
| 08/13/2009 | CA2714272A1 Therapeutic treatment for lung conditions |
| 08/13/2009 | CA2713525A1 Compositions methods and kits for enhancing immune response to a respiratory condition |
| 08/13/2009 | CA2713322A1 Compounds |
| 08/13/2009 | CA2712574A1 Polymorphic form of a [1,2,4]triazolo[4,3-a]pyridine derivative for treating inflammatory diseases |
| 08/13/2009 | CA2711582A1 Spirocyclic heterocycles, medicaments containing said compounds, use thereof and processes for the preparation thereof |
| 08/13/2009 | CA2711399A1 3-substituted sulfonylpiperidine derivative |
| 08/12/2009 | EP2088197A2 Haemophilus influenzae antigens and corresponding DNA fragments |
| 08/12/2009 | EP2087903A1 Extract powder of indigo-containing plant, method for production thereof, and use thereof |
| 08/12/2009 | EP2087892A2 (S,S) reboxetine for treating age associated learning and mental disorders |
| 08/12/2009 | EP2087891A2 Pharmaceutical compositions for treating lymphoma |
| 08/12/2009 | EP2087890A1 Sustained release preparation for tissue regeneration therapy |
| 08/12/2009 | EP2087008A1 TREATMENT AND PREVENTION OF CHRONIC ASTHMA USING ANTAGONISTS OF INTEGRIN alphaVbeta6 |
| 08/12/2009 | EP2086947A1 Pyrimidines and their use as cxcr2 receptor antagonists |
| 08/12/2009 | EP2086641A2 Egfr kinase inhibitor combinations for the treatment of respiratory and gastrointestinal disorders |
| 08/12/2009 | EP1682121B1 Use of crth2 antagonist compounds in therapy |
| 08/12/2009 | EP1636221B1 3-Heterocyclyl-Azetidine compounds useful as NK1/NK2 receptors antagonists |
| 08/12/2009 | EP1409645B1 Probiotic lactobacillus salivarius strains |
| 08/12/2009 | EP1385514B9 Spiroindene and spiroindane compounds |
| 08/12/2009 | EP0788360B3 Boronic ester and acid compounds, synthesis and uses |
| 08/12/2009 | EP0771322B9 Abundant extracellular products and methods for their production and use |
| 08/12/2009 | CN101506205A Polymorph of (R) -3- (2-hydroxy-2, 2-diphenyl-acetoxy) -1- (isoxazol-3-ylcarbamoyl-methyl) -1-azoni a-bicyclo- [2.2.2] octane bromide |
| 08/12/2009 | CN101506182A Single enantiomer beta agonists method for production and use thereof as a medicament |
| 08/12/2009 | CN101506171A Isoquinoline derivatives and their use as inhibitors of cytokine mediated diseases |
| 08/12/2009 | CN101506145A Aminoalcohol derivative and immunosuppressant containing the same as active ingredient |
| 08/12/2009 | CN101505798A Aerosol formulation for the inhalation of beta agonists |
| 08/12/2009 | CN101505791A Diagnosis and treatment of cancer using anti-desmoglein-3 antibody |
| 08/12/2009 | CN101505763A Modulation of the immune system by inositol phospholipids |
| 08/12/2009 | CN101505761A Pharmaceutical compositions for the treatment of inflammatory or obstructive airway diseases |
| 08/12/2009 | CN101505758A Pharmaceutical containing thiazole derivative as active ingredient |
| 08/12/2009 | CN101505757A Drug combinations for treating airway diseases |
| 08/12/2009 | CN101504396A Method for detecting eedysterone in medicine composition |
| 08/12/2009 | CN101502648A 疫苗 Vaccine |
| 08/12/2009 | CN101502644A Applications of hCRF and derivatives thereof in preparing medicament for treating alveolar hypoventilation syndrome |
| 08/12/2009 | CN101502628A Tibetan medicine pill for influenza as well as quality criteria and inspection method of preparation thereof |
| 08/12/2009 | CN101502623A Quality control method of tracheitis pill preparation |
| 08/12/2009 | CN101502618A Chinese medicinal composition for treating cough and asthma of children |
| 08/12/2009 | CN101502617A Chinese medicinal composition with cough-suppressing phlegm-dispelling functions and preparation method thereof |
| 08/12/2009 | CN101502614A Medicine tea for stopping snore |
| 08/12/2009 | CN101502579A Chinese medicinal composition for treating digestive tumor and preparation method thereof |
| 08/12/2009 | CN101502566A Chinese medicament preparation for preventing and treating fowl respiratory disease and preparation method thereof |
| 08/12/2009 | CN101502553A Rhizoma atractylodis total terpene alcohol solid dispersoid, medicament composition and preparation method thereof |
| 08/12/2009 | CN101502535A Selaginella uncinata extract as well as preparation method and application thereof |
| 08/12/2009 | CN101502528A Application of esculentoside A in preparing medicament for preventing or treating pulmonary fibrosis |
| 08/12/2009 | CN101502524A Application of acetyl-fluorobenzene salicylamide compound in preparing anti-tumor medicament |
| 08/12/2009 | CN101502523A Application of benzoyl fluorobenzene salicylamide compound in preparing anti-tumor medicament |
| 08/12/2009 | CN101502516A Glipizide enteric-coated formulation composition and method for preparing the same |
| 08/12/2009 | CN101502515A Hydrochloride loratadine enteric-coated formulation composition and method for preparing the same |
| 08/12/2009 | CN101502500A Pressurised metered dose inhalers containing solutions of beta-2 agonists |
| 08/12/2009 | CN101502495A Pemirolast Potassium and technique for producing the same |
| 08/12/2009 | CN101502494A Bromhexine hydrochloride freeze-dried injection and preparation method thereof |
| 08/12/2009 | CN101502291A Chinese herbal compound bag tea preparation for treating phlegm-fluid retention symptoms caused by lung and spleen yang deficiency |
| 08/12/2009 | CN100526309C Dimeric compounds and their use as anti-viral agents |
| 08/12/2009 | CN100526307C Metalloproteinase inhibitors |
| 08/12/2009 | CN100525811C Chinese traditional medicine paste for treating cough and bronchitis for children |
| 08/12/2009 | CN100525773C Injectable azithromycin freeze-dried powder, and its preparation method |
| 08/12/2009 | CN100525770C Oral compound slow-released pharmaceutics containing theine and salmol active constituent and preparation process thereof |
| 08/12/2009 | CN100525768C Novel compounds |
| 08/12/2009 | CN100525763C Mono- and bicyclic azole derivatives that inhibit the interaction of ligands with rage |
| 08/11/2009 | US7572915 Quinoline derivatives as phosphodiesterase inhibitors |
| 08/11/2009 | US7572817 Carboxypeptidase U inhibitors; thrombosis, atherosclerosis, adhesions, dermal scarring, cancer, fibrotic conditions, inflammatory diseases; e.g. 2-[(6-Aminopyridin-3-yl)methyl]-3-mercapto-5-[3-(pyrrolidin-1-ylcarbonyl)phenyl]pentanoic acid |
| 08/11/2009 | US7572815 Amide derivative |